EverGlade Cosnulting White Logo

EverGlade News

Industrail Base Expansion (IBx) mRNA vaccine programs

EverGlade Consulting Plays Key Role on Industrial Base Expansion (IBx) Project with $39 Million in Federal Funding Secured

EverGlade Consulting (“EverGlade”), a national consulting firm, has successfully partnered with a global leader in mRNA materials used for research, diagnostics, and therapeutics, to successfully manage $39 million in federal funding. The Industrial Base Expansion (IBx) project will expand the domestic production capacity for materials that are critical to the development and manufacture of mRNA …

EverGlade Consulting Plays Key Role on Industrial Base Expansion (IBx) Project with $39 Million in Federal Funding Secured Read More »

Monkeypox Virus declared a Public Health Emergency

Monkeypox: Public Health Emergency (PHE) Designation

As of August 10, the Center for Disease Control (CDC) reported that over 10,000 cases of monkeypox have been identified in the United States (US). The Biden administration officially declared monkeypox a Public Health Emergency (PHE) in the US on August 4th, following several states that declared their own state of emergency (New York, California, …

Monkeypox: Public Health Emergency (PHE) Designation Read More »

Government Funding Opportunities in Medical manufacturing

New Government Funding Opportunities for Medical Research and Development

With the government fiscal year ending in a few short weeks and Covid continuing to impact the country, new government funding opportunities are plentiful for organizations supporting both the pandemic response and other areas of interest in the new Senate appropriations bill which will head for a vote by September 30, 2022. One of the …

New Government Funding Opportunities for Medical Research and Development Read More »

Federal Funding for Development

EverGlade Assists Detect, Inc. with $22m in Federal Funding

EverGlade Consulting (“EverGlade”), a Washington, D.C. based consulting firm, has successfully aided Detect, Inc. (“Detect”) in securing a contract with BARDA for the advanced development of a next-generation diagnostic device which is an over-the-counter home test that identifies and distinguishes between SARS-CoV-2 and influenza A and B nucleic acid using a single nasal swab.   …

EverGlade Assists Detect, Inc. with $22m in Federal Funding Read More »

Capitol Building Capitol Building

New Funding Opportunities Abound for Pandemic Response

With BARDA Industry Day kicking off on November 3, 2021, new opportunities abound for organizations supporting the pandemic response. These include an updated BARDA Broad Agency Announcement (“BAA”), a new Commercial Solutions Opening (“CSO”) from the Department of the Air Force Acquisition COVID-19 Task Force (DAF ACT) with three new Areas of Interest, and a …

New Funding Opportunities Abound for Pandemic Response Read More »

Scroll to Top